TGF-β1 system in leydig cells. Part I: Effect of hCG and progesterone

Journal of Reproduction and Development

Volumn 56, Issue 4, 2010, Pages 389-395

  Gonzalez, Candela R ^a   Gonzalez, Betina ^a   Rulli, Susana B ^a   Huhtaniemi, Ilpo ^b   Calandra, Ricardo S ^a   Gonzalez Calvar, Silvia I ^a,c  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

ALK; Endoglin (CD105); Leydig; Testis; TGF beta 1

Indexed keywords

ANIMALIA; MUS;

ACTIVIN RECEPTOR 1; ACVRL1 PROTEIN, MOUSE; CHORIONIC GONADOTROPIN; ENDOGLIN PROTEIN, MOUSE; PROGESTERONE; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

AGE; ANIMAL; ARTICLE; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LEYDIG CELL; MALE; METABOLISM; MOUSE; PHYSIOLOGY; SEXUAL MATURATION; TRANSGENIC MOUSE;

ACTIVIN RECEPTORS, TYPE I; AGE FACTORS; ANIMALS; CELLS, CULTURED; CHORIONIC GONADOTROPIN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEYDIG CELLS; MALE; MICE; MICE, TRANSGENIC; PROGESTERONE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SEXUAL MATURATION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77956593693     PISSN: 09168818     EISSN: 13484400     Source Type: Journal    
DOI: 10.1262/jrd.09-166N     Document Type: Article

References (29)

1. Sharpe RM, Kerr JB, McKinnell C, Millar M. Temporal relationship between androgen- dependent changes in the volume of seminiferous tubule fluid, lumen size and seminiferous tubule protein secretion in rats. J Reprod Fertil 1994; 101: 193-198.
2. Massagué J, Wotton D. Transcriptional control by TGF-β/Smad signaling system. EMBO J 2000; 19: 1745-1754.
3. Massague J, Gomis RR. The logic of TGFbeta signaling. FEBS Letters 2006; 580: 2811-2820.
4. Teerds KJ, Dorrington JH. Localization of transforming growth factor beta1 and beta2 during testicular development in the rat. Biol Reprod 1993; 48: 40-45.
5. Itman C, Mendis S, Barakat B, Loveland KL. Focus on TGF-β signaling. All in the family: TGF-β family action in testis development. Reproduction 2006; 132: 233-246.
6. Gautier C, Levacher C, Saez JM, Habert R. Transforming growth factor beta1 inhibits steroidogenesis in dispersed fetal testicular cells in culture. Mol Cell Endocrinol 1997, 131: 21-30.
7. Gnessi L, Fabbri A, Spera G. Gonadal peptides as mediators of development and functional control of the testis: an integrated system with hormones and local environment. Endocr Rev 1997; 18: 541-609.
8. Avallet O, Vigier M, Leduque P, Dubois, PM, Saez JM. Expression and regulation of transforming growth factor-beta 1 messenger ribonucleic acid and protein in cultured porcine Leydig and Sertoli cells. Endocrinology 1994; 134: 2079-2087.
9. Goddard I, Bouras M, Keramidas M, Hendrick JC, Feige JJ, Benahmed M. Transforming growth factor-beta receptor types I and II in cultured porcine Leydig cells: expression and hormonal regulation. Endocrinology 2000, 141: 2068-2074.
10. Rulli SB, Ahtiainen P, Makela S, Toppari J, Poutanen M, Huhtaniemi I. Elevated steroidogenesis, defective reproductive organs, and infertility in transgenic male mice overexpressing human chorionic gonadotropin. Endocrinology 2003; 144: 4980-4990.
11. Ahtiainen P, Rulli SB, Shariatmadami R, Pelliniemi LJ, Toppari J, Poutanen M, Huhtaniemi I. Fetal but not adult Leydig cells are susceptible to adenoma formation in response to persistently high level: a study on hCG overexpressing transgenic mice. Oncogene 2005; 24: 7301-7309.
12. Kim IY, Kim MM, Kim S-J. Transforming growth factor β: Biology and clinical relevance. J Biochem Mol Biol 2005; 38: 1-8.
13. Rulli SB, Kuorelahti A, Karaer O, Pelliniemi LJ, Poutanen M, Huhtaniemi I. Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic mice producing high levels of human chronic gonadotropin. Endocrinology 2002; 143: 4084-4095.
14. Frungieri MB, Mayerhofer A, Zitta K, Pignataro OP, Calandra RS, Gonzalez-Calvar SI. Direct effect of melatonin on Syrian hamster testes: melatonin subtype 1a receptors, inhibition of androgen production, and interaction with the local corticotropinreleasing hormone system. Endocrinology 2005; 146: 1541-1552.
15. Levy H, Deane HW, Rubin BL. Visualization of steroid 3β-ol-dehydrogenase activity in tissues of intact and hypophysectomized rats. Endocrinology 1959; 65: 932-943.
16. Ingman WV, Robertson SA. Defining the actions of transforming growth factor beta in reproduction. Bioessays 2002: 24: 904-914.
17. Zhang YQ, He XZ, Zhang JS, Wang RA, Zhou J, Xu RJ. Stage-specific localization of transforming growth factor β1 and β3 and their receptors during spermatogenesis in men. Asian J Androl 2004; 6: 105-109.
18. Dickson C, Webster DR, Johnson H, Millena CA, Khan SA. Transforming growth factor-beta effects on morphology of immature rat Leydig cells. Mol Cell Endocrinol 2002; 195: 65-77.
19. Olaso R, Pairault C, Habert R. Expression of type I and II receptors for transforming growth factor beta in the adult rat testis. Histochem Cell Biol 1998; 110: 613-618.
20. Oh SP, Seki T, Hoss KA, Imamura T, Yi Y, Donahoe PK, Li L, Miyazono K, ten Dijke P, Kim S, Li E. Activin receptor-like kinase 1 modulates transforming growth factor-β 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci USA 1999; 97: 2626-2631.
21. Fonsatti E, Del Vecchio L, Altomonte M, Sigalotti L, Nicotra MR, Coral S, Natali PG, Maio M. Endoglin: An accessory component of the TGFβ-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignacies. J Cell Physiol 2001; 188: 1-7.
22. Lebrin F, Goumans MJ, Jonker L, Carvalho RLC, Valdimarsdottir G, Thorikay M, Mummery C, Arthur HM, ten Dijke P. Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduction. EMBO J 2004; 23: 4018-4028.
23. Koleva RI, Conley BA, Romero D, Riley KS, Marto JA, Lux A, Vary CPH. Endoglin structure and function. Determinants of endoglin phosphorylation by transforming growth factor-β receptors. J Biol Chem 2006; 281: 25110-25123.
24. St-Jaques S, Cymerman U, Pece N, Letarte M. Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-β binding protein of endothelial and stromal cells. Endocrinology 1994; 134: 2645-2657.
25. Barbara NP, Wrana JL, Letarte M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor- β superfamily. J Biol Chem 1999; 274: 584-594.
26. Lebrin F, Mummery CL. Endoglin-mediated vascular remodeling: mechanisms underlying hereditary hemorrhagic telangiectasia. Trends Cardiovasc Med 2008; 18: 25-32.
27. Blanco FJ, Santibañez JF, Guerrero-Esteo M, Langa C, Vary CP, Bernabeu C. Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex. J Cell Physiol 2005; 204: 574-584.
28. Lutz M, Knaus P. Integration of the TGF-β into the cellular signaling network. Cell Signal 2002; 14: 977-988.
29. Suszko MI, Woodruf TK. Cell-specificity of transforming growth factor-beta response is dictated by receptor bioavailability. J Mol Endocrinol 2006; 36: 591-600.